about
Statins for primary prevention of venous thromboembolismStatins for primary prevention of venous thromboembolismStatins for prevention of venous thromboembolismPrevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesModels for thrombin generation and risk of diseaseWeibel-Palade body size modulates the adhesive activity of its von Willebrand Factor cargo in cultured endothelial cells.Haemostasis, inflammation and renal function following exercise in patients with intermittent claudication on statin and aspirin therapyEffect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trialsAtorvastatin downregulates tissue plasminogen activator-aggravated genes mediating coagulation and vascular permeability in single cerebral endothelial cells captured by laser microdissection.Systemic effects of inflammation on health during chronic HIV infectionRisk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial.Influence of blood lipids on global coagulation test results.Thrombin generation in the Glasgow Myocardial Infarction Study.Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome.The association between statin therapy during intensive care unit stay and the incidence of venous thromboembolism: a propensity score-adjusted analysis.Host cell invasion by Staphylococcus aureus stimulates the shedding of microvesicles.Circulatory syndrome: an evolution of the metabolic syndrome concept!Frequency and predictors of symptomatic intracranial hemorrhage after intravenous thrombolysis for acute ischemic stroke in a Brazilian public hospital.Antibacterial activity of statins: a comparative study of atorvastatin, simvastatin, and rosuvastatin.Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromsø Study.Receptors, rafts, and microvesicles in thrombosis and inflammation.Statin Therapy and the Development of Cerebral Amyloid Angiopathy--A Rodent in Vivo Approach.Review article: The role of statins in reducing perioperative cardiac risk: Physiologic and clinical perspectives.A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction.Statins improve human coronary atherosclerotic plaque morphology.Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome.Short-term high-dose effect of lovastatin on thrombolysis by rt-PA in a human whole-blood in vitro clot model.Statin therapy and levels of hemostatic factors in a healthy population: the Multi-Ethnic Study of Atherosclerosis.The association of statin therapy with the risk of recurrent venous thrombosis.The effect of nine common polymorphisms in coagulation factor genes (F2, F5, F7, F12 and F13 ) on the effectiveness of statins: the GenHAT study.A randomized trial of rosuvastatin in the prevention of venous thromboembolism.Tissue factor in the antiphospholipid syndrome.Statin treatment and risk of recurrent venous thromboembolism: a nationwide cohort studyPravastatin-induced proangiogenic effects depend upon extracellular FGF-2.Statins and amyotrophic lateral sclerosis--the level of evidence for an association.Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study.Statins and secondary prevention of venous thromboembolism: pooled analysis of published observational cohort studies.Statins and venous thromboembolism: do they represent a viable therapeutic agent?Simvastatin given for 3 days can inhibit thrombin generation and activation of factor V and enhance factor Va inactivation in hypercholesterolemic patients.Paraoxonase-1 and Simvastatin Treatment in Patients with Stable Coronary Artery Disease
P2860
Q24187238-952E2F3B-3B39-427F-8730-29E88E30F215Q24204040-2DA262B5-0F5B-439D-A723-476B09000A8AQ24241510-9F705733-BC5B-4BE8-B992-C44FB189D6F4Q24633010-9E8D873D-7590-4BC0-8F70-D1F8ED19BFFBQ27013171-A5951A37-F5EE-475D-B070-D722C02B745BQ27313693-0FCEFE3D-503F-4D33-806E-FCBAAB3AD557Q28199579-1C23B822-7F4D-4580-A7C4-18DF3702E6BAQ28483807-AA7F62BD-CFFF-4B7B-ABB8-1D3997D32F31Q33223756-C34E37CE-BB9E-46DC-8858-7A2DDFC3C3F8Q33577551-8B9DAB5C-43AB-4F5A-87F5-DCABA0FFA6A3Q34576644-0D635388-2B4F-40A7-B7C1-E33B1EF1626EQ34749623-EDC3C975-EEAA-494C-851F-F57E3E066978Q34796302-F1DEE221-4C7A-496C-912E-48777CD5236FQ35007498-7670DA01-3D36-477A-81FF-86F0B5974DA6Q35037358-657E8D0C-946C-45A9-ABF3-F5D379D7E8B4Q35695065-34BE628F-8128-4DF7-849F-05FFD184D15DQ36087928-2E06379C-10D8-4AFF-B9F0-AA2C883120D5Q36104057-EF959BCF-4D66-46EB-98C8-23C24C20CF32Q36127865-C17C96C8-906E-4003-9EB4-53207A716ECFQ36135460-7AC6AE1C-A4FD-41E5-985F-F1224683D172Q36230863-9A826C02-09DB-4B4A-AFA7-C5F6D9D2B9B6Q36512688-90EB08DD-8375-4AD2-99FA-7EEFE278FC7DQ36641901-9735C643-0F37-4C42-B860-0E48D92178A3Q36697677-2D59D9B1-4EA0-4FE9-AD09-C1AE0DEBA5D3Q36732164-CF338E7F-BC2C-4AA7-BDE2-33A739B00CA7Q36807512-45C5DB38-FB2C-491C-ACE5-51913A4D38A9Q36876792-98F12C2A-29FF-4D63-8C18-BD701B12A258Q36986116-F718A62E-B410-4976-8A2C-FE5F53E5493EQ37138335-73D6BEC4-2EBA-4FB7-841C-2912C40E2245Q37240345-A92843BB-C776-45B0-B4F1-7741B311D6D5Q37262627-42707C76-C3C1-45CD-AF60-BCC3823105D0Q37283046-494DA996-35D0-46CF-A141-4CB3891470C3Q37293275-CFC2790D-D519-43A6-B349-97C238F33C65Q37294891-D8E93B7C-CAC8-4D3A-805C-B7648E6AD0F2Q37636347-DD73A754-491C-4CAC-A9C2-440B53D31646Q38471162-1FC43B74-EFB3-439C-809A-9EA8598B95DEQ39215531-DAEDF512-949D-40C4-9C3E-25EBE7FEFA2DQ39445730-C37C90F0-E48F-4C6D-BAA4-C2E33EC0B436Q40073814-22F7B858-749A-422F-A68F-0B81151DC546Q41149701-944D8151-4E79-4F20-9194-CA3772898C00
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Statins and blood coagulation.
@ast
Statins and blood coagulation.
@en
type
label
Statins and blood coagulation.
@ast
Statins and blood coagulation.
@en
prefLabel
Statins and blood coagulation.
@ast
Statins and blood coagulation.
@en
P1476
Statins and blood coagulation.
@en
P2093
Kathleen E Brummel-Ziedins
Kenneth G Mann
P304
P356
10.1161/01.ATV.0000151647.14923.EC
P50
P577
2004-11-29T00:00:00Z